Cover Image

Prescription drug and price advertising : hearings before the Subcommittee on Consumer Protection and Finance of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fourth Congress, second session, on H.R. 882, H.R. 884, and all identical bills ...

Bibliographic Details
Corporate Authors:	United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Consumer Protection and Finance, ProQuest (Firm)
Format:	Government Document eBook
Language:	English
Published:	Washington : U.S. Govt. Print. Off, 1976.
Series:	U.S. Congressional Hearings.
Subjects:	Drugs > Labeling > United States. Prescription pricing > Law and legislation > United States. Pharmacy > Law and legislation > United States. Electronic books.
Online Access:	Connect to the full text of this electronic book

Similar Items

Prescription drugs : prices available through discount cards and from other sources.
by: Dummit, Laura A.
Published: (2001)

Prescription drug prices : should the federal government regulate them? /
by: Guenther, Gary
Published: (1992)

Medicaid prescription drug pricing : hearing before the Subcommittee on Health for Families and the Uninsured of the Committee on Finance, United States Senate, One Hundred First Congress, second session, on S. 2605 and S. 3029, September 17, 1990.
Published: (1991)

Medicare Prescription Drug Benefit Amendment to H.R. 2470, the Medicare Catastrophic Protection Act of 1987 : Recommendations of the Subcommittee on Health. /
Published: (1987)

Lowering prescription drug prices : deconstructing the drug supply chain : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, May 9, 2019.
Published: (2021)

Medicare prescription drug benefits : hearing before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, One Hundred Second Congress, first session, June 11, 1991.
Published: (1992)

The politics of the international pricing of prescription drugs /
by: Harrison, Christopher Scott
Published: (2004)

Reauthorization of the Prescription Drug User Fee Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, March 6, 2002.
Published: (2002)

Reauthorization of the Prescription Drug User Fee Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, March 6, 2002.
Published: (2002)

Republican Prescription Drug Legislation (H.R. 4954) Will Not End Drug Price Discrimination /
Published: (2002)

Reauthorization of the Prescription Drug User Fee Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, April 17, 2007.
Published: (2008)

Reauthorization of the Prescription Drug User Fee Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, April 17, 2007.
Published: (2008)

Prescription and non-prescription drugs /
by: Ruschmann, Paul
Published: (2007)

Substitute prescription drug act : hearings before the Subcommittee on Consumer Protection and Finance of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fifth Congress, second session, on H.R. 1963 ... June 22 and July 27, 1978.
Published: (1978)

H.R. 1963, the substitute prescription drug act : report of the Subcommittee on Consumer Protection and Finance of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fifth Congress, second session.
Published: (1978)

Why does the U.S. pay the highest prices in the world for prescription drugs? : hearing before the Subcommittee on Primary Health and Retirement Security of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Seventeenth Congress, first session on examining why the U.S. pays the highest prices in the world for prescription drugs, March 23, 2021.
Published: (2022)

Prescription drug user fee act of 1992 : effects on bringing new drugs to market /
by: Cantor, David J.
Published: (1997)

Why does the United States pay, by far, the highest prices in the world for prescription drugs? : hearing of the Committee on Health, Education, Labor and Pensions, United States Senate, One Hundred Eighteenth Congress, second session, on examining the cost of prescription drugs, February 8, 2024.
Published: (2024)

Expanding coverage of prescription drugs in Medicare : hearing before the Committee on Ways and Means, U.S. House of Representatives, One Hundred Eighth Congress, first session, April 9, 2003.
Published: (2003)

Prescription drug advertising to consumers : staff report /
Published: (1984)

Affordable Prescriptions for Patients Through Promoting Competition Act of 2019 : report (to accompany H.R 5133).
Published: (2020)

Examining prescription drug importation : a review of a proposal to allow third parties to reimport prescription drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, July 25, 2002.
Published: (2002)

Brand-name prescription drug pricing : lack of therapeutically equivalent drugs and limited competition may contribute to extraordinary price increases : report to congressionals requesters.
Published: (2009)

Prescription drug prices : are we getting our money's worth? : a majority staff report of the Special Committee on Aging, United States Senate.
Published: (1989)

Importation of prescription drugs : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Eighth Congress, second session, on examining prescription drug reimportation, focusing on efforts to reduce drug costs, patient safety concerns, recent state action, fraudulent and counterfeit drugs, an international comparison of rising prescription drug expenditures, and S. 2328, to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, May 20, 2004.
Published: (2005)

Importation of prescription drugs : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Eighth Congress, second session, on examining prescription drug reimportation, focusing on efforts to reduce drug costs, patient safety concerns, recent state action, fraudulent and counterfeit drugs, an international comparison of rising prescription drug expenditures, and S. 2328, to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, May 20, 2004.
Published: (2005)

Third party prepaid prescription programs : hearings, Ninety-second Congress, first session, pursuant to H. Res. 5 and 19 ... July 7, 8, and 9, 1971.
Published: (1971)

Report on prescription drug importation /
Published: (2004)

Physician dispensing of drugs : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One hundredth Congress, first session on H.R. 2093 ... April 22, 1987.
Published: (1987)

Market restraints in the retail drug industry.
by: Fletcher, F. Marion
Published: (1967)

Response to Drug Industry Claims on Prescription Drug Price Differences Between the U.S. and Other Countries /
Published: (2002)

Measuring prescription drug prices : a primer on the CPI Prescription Drug Index /
Published: (2019)

Requesting the President and directing the Secretary of Health and Human Services provide certain documents to the House of Representatives relating to estimates and analyses of the cost of the medicare prescription drug legislation : adverse report together with dissenting views (to accompany H.Res. 776) (including cost estimate of the Congressional Budget Office).
Published: (2004)

Expanding coverage of prescription drugs in Medicare : hearing before the Committee on Ways and Means, U.S. House of Representatives, One Hundred Eighth Congress, first session, April 9, 2003.
Published: (2003)

A prescription for safety : the need for H.R. 3880, the Internet Pharmacy Consumer Protection Act : hearing before the Committee on Government Reform, House of Representatives, One Hundred Eighth Congress, second session, March 18, 2004.
Published: (2004)

Guide to prescription drug costs /
Published: (1980)

Prescription Drug Prices in Canada, Europe, and Japan /
Published: (2001)

Prescription drug pricing : implications for retail pharmacies : statement of Sarah F. Jaggar, Director, Health Services Quality and Public Health, Health, Education, and Human Services Division, before the Subcommittee on Oversight and Investigations, Committee on Commerce, House of Representatives /
by: Jaggar, Sarah F.
Published: (1996)

Reauthorization of the Prescription User Fee Act and FDA reform : hearing before the Subcommittee on Health and Environment of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, first session, April 23, 1997.
Published: (1997)

Prescription drug price increases : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, first session, July 15, 1985.
Published: (1986)